Homocysteine potentiates amyloid
Alzheimer's disease
amyloid beta
angiogenesis
apoptosis
blood brain barrier
cardiovascular risk
cerebral amyloid angiopathy
cerebrovascular dysfunction
endothelial cells
hyperhomocysteinemia
Journal
Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839
Informations de publication
Date de publication:
15 Feb 2024
15 Feb 2024
Historique:
revised:
10
01
2024
received:
05
12
2023
accepted:
17
01
2024
medline:
15
2
2024
pubmed:
15
2
2024
entrez:
15
2
2024
Statut:
aheadofprint
Résumé
Cerebrovascular dysfunction has been implicated as a major contributor to Alzheimer's Disease (AD) pathology, with cerebral endothelial cell (cEC) stress promoting ischemia, cerebral-blood flow impairments and blood-brain barrier (BBB) permeability. Recent evidence suggests that cardiovascular (CV)/cerebrovascular risk factors, including hyperhomocysteinemia (Hhcy), exacerbate AD pathology and risk. Yet, the underlying molecular mechanisms for this interaction remain unclear. Our lab has demonstrated that amyloid beta 40 (Aβ40) species, and particularly Aβ40-E22Q (AβQ22; vasculotropic Dutch mutant), promote death receptor 4 and 5 (DR4/DR5)-mediated apoptosis in human cECs, barrier permeability, and angiogenic impairment. Previous studies show that Hhcy also induces EC dysfunction, but it remains unknown whether Aβ and homocysteine function through common molecular mechanisms. We tested the hypotheses that Hhcy exacerbates Aβ-induced cEC DR4/5-mediated apoptosis, barrier dysfunction, and angiogenesis defects. This study was the first to demonstrate that Hhcy specifically potentiates AβQ22-mediated activation of the DR4/5-mediated extrinsic apoptotic pathway in cECs, including DR4/5 expression, caspase 8/9/3 activation, cytochrome-c release and DNA fragmentation. Additionally, we revealed that Hhcy intensifies the deregulation of the same cEC junction proteins mediated by Aβ, precipitating BBB permeability. Furthermore, Hhcy and AβQ22, impairing VEGF-A/VEGFR2 signaling and VEGFR2 endosomal trafficking, additively decrease cEC angiogenic capabilities. Overall, these results show that the presence of the CV risk factor Hhcy exacerbates Aβ-induced cEC apoptosis, barrier dysfunction, and angiogenic impairment. This study reveals specific mechanisms through which amyloidosis and Hhcy jointly operate to produce brain EC dysfunction and death, highlighting new potential molecular targets against vascular pathology in comorbid AD/CAA and Hhcy conditions.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14106Informations de copyright
© 2024 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Références
xxxx. (2020). Alzheimer's disease facts and figures. Alzheimers Dement. https://doi.org/10.1002/alz.12068
Ali, M., & Bracko, O. (2022). VEGF paradoxically reduces cerebral blood flow in Alzheimer's disease mice. Neuroscience Insights, 17, 26331055221109254. https://doi.org/10.1177/26331055221109254
Ali, M., Falkenhain, K., Njiru, B. N., Murtaza-Ali, M., Ruiz-Uribe, N. E., Haft-Javaherian, M., Catchers, S., Nishimura, N., Schaffer, C. B., & Bracko, O. (2022). VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice. Brain, 145(4), 1449-1463. https://doi.org/10.1093/brain/awab387
Balaji Ragunathrao, V. A., Vellingiri, V., Anwar, M., Akhter, M. Z., & Mehta, D. (2020). S1PR1 and VEGFR2-a synergy that promotes tumor angiogenesis? Molecular & Cellular Oncology, 7(4), 1746131. https://doi.org/10.1080/23723556.2020.1746131
Balint, B., Jepchumba, V. K., Gueant, J. L., & Gueant-Rodriguez, R. M. (2020). Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall. Biochimie, 173, 100-106. https://doi.org/10.1016/j.biochi.2020.02.012
Beard, R. S., Jr., Reynolds, J. J., & Bearden, S. E. (2011). Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood, 118(7), 2007-2014. https://doi.org/10.1182/blood-2011-02-338269
Beck, H., & Plate, K. H. (2009). Angiogenesis after cerebral ischemia. Acta Neuropathologica, 117(5), 481-496. https://doi.org/10.1007/s00401-009-0483-6
Braun, D. J., Abner, E., Bakshi, V., Goulding, D. S., Grau, E. M., Lin, A. L., Norris, C. M., Sudduth, T. L., Webster, S. J., Wilcock, D. M., & Van Eldik, L. J. (2019). Blood flow deficits and cerebrovascular changes in a dietary model of hyperhomocysteinemia. ASN Neuro, 11, 1759091419865788. https://doi.org/10.1177/1759091419865788
Canepa, E., Parodi-Rullan, R., Vazquez-Torres, R., Gamallo-Lana, B., Guzman-Hernandez, R., Lemon, N. L., Angiulli, F., Debure, L., Ilies, M. A., Østergaard, L., Wisniewski, T., Gutiérrez-Jiménez, E., Mar, A. C., & Fossati, S. (2023). FDA-approved carbonic anhydrase inhibitors reduce amyloid beta pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness. Alzheimer's & Dementia, 19, 5048-5073. https://doi.org/10.1002/alz.13063
Carey, A., & Fossati, S. (2023). Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers. Alzheimers Dement, 19(2), 671-695. https://doi.org/10.1002/alz.12871
Chen, J., Huang, Y., Hu, X., Bian, X., & Nian, S. (2021). Gastrodin prevents homocysteine-induced human umbilical vein endothelial cells injury via PI3K/Akt/eNOS and Nrf2/ARE pathway. Journal of Cellular and Molecular Medicine, 25(1), 345-357. https://doi.org/10.1111/jcmm.16073
Chen, Q., Xu, H., Xu, A., Ross, T., Bowler, E., Hu, Y., & Lesnefsky, E. J. (2015). Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria. PLoS ONE, 10(3), e0118834. https://doi.org/10.1371/journal.pone.0118834
Cortes-Canteli, M., & Iadecola, C. (2020). Alzheimer's disease and vascular aging: JACC focus seminar. Journal of the American College of Cardiology, 75(8), 942-951. https://doi.org/10.1016/j.jacc.2019.10.062
Cuevas, E., Rosas-Hernandez, H., Burks, S. M., Ramirez-Lee, M. A., Guzman, A., Imam, S. Z., Ali, S. F., & Sarkar, S. (2019). Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro. Metabolic Brain Disease, 34(5), 1365-1374. https://doi.org/10.1007/s11011-019-00447-8
Cullen, S. P., & Martin, S. J. (2009). Caspase activation pathways: Some recent progress. Cell Death and Differentiation, 16(7), 935-938. https://doi.org/10.1038/cdd.2009.59
DeTure, M. A., & Dickson, D. W. (2019). The neuropathological diagnosis of Alzheimer's disease. Molecular Neurodegeneration, 14(1), 32. https://doi.org/10.1186/s13024-019-0333-5
Di Marco, L. Y., Venneri, A., Farkas, E., Evans, P. C., Marzo, A., & Frangi, A. F. (2015). Vascular dysfunction in the pathogenesis of Alzheimer's disease-A review of endothelium-mediated mechanisms and ensuing vicious circles. Neurobiology of Disease, 82, 593-606. https://doi.org/10.1016/j.nbd.2015.08.014
Dietrich, J. B. (2002). The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. Journal of Neuroimmunology, 128(1-2), 58-68. https://doi.org/10.1016/s0165-5728(02)00114-5
Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicologic Pathology, 35(4), 495-516. https://doi.org/10.1080/01926230701320337
Fan, X., Wang, E., He, J., Zhang, L., Zeng, X., Gui, Y., Sun, Q., Song, Y., & Yuan, H. (2019). Ligustrazine protects homocysteine-induced apoptosis in human umbilical vein endothelial cells by modulating mitochondrial dysfunction. Journal of Cardiovascular Translational Research, 12(6), 591-599. https://doi.org/10.1007/s12265-019-09900-6
Fanning, A. S., Jameson, B. J., Jesaitis, L. A., & Anderson, J. M. (1998). The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the Actin cytoskeleton. The Journal of Biological Chemistry, 273(45), 29745-29753. https://doi.org/10.1074/jbc.273.45.29745
Faraci, F. M., & Lentz, S. R. (2004). Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke, 35(2), 345-347. https://doi.org/10.1161/01.STR.0000115161.10646.67
Finnberg, N., Klein-Szanto, A. J., & El-Deiry, W. S. (2008). TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis. The Journal of Clinical Investigation, 118(1), 111-123. https://doi.org/10.1172/JCI29900
Fossati, S., Cam, J., Meyerson, J., Mezhericher, E., Romero, I. A., Couraud, P. O., Weksler, B. B., Ghiso, J., & Rostagno, A. (2010). Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-beta variants in cells composing the cerebral vessel walls. The FASEB Journal, 24(1), 229-241. https://doi.org/10.1096/fj.09-139584
Fossati, S., Ghiso, J., & Rostagno, A. (2012a). Insights into caspase-mediated apoptotic pathways induced by amyloid-beta in cerebral microvascular endothelial cells. Neurodegenerative Diseases, 10(1-4), 324-328. https://doi.org/10.1159/000332821
Fossati, S., Ghiso, J., & Rostagno, A. (2012b). TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Abeta. Cell Death & Disease, 3(6), e321. https://doi.org/10.1038/cddis.2012.55
Frangione, B., Revesz, T., Vidal, R., Holton, J., Lashley, T., Houlden, H., Wood, N., Rostagno, A., Plant, G., & Ghiso, J. (2001). Familial cerebral amyloid angiopathy related to stroke and dementia. Amyloid, 8(1), 36-42. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11676288
Fukushi, J., Morisaki, T., Shono, T., Nishie, A., Torisu, H., Ono, M., & Kuwano, M. (1998). Novel biological functions of interleukin-4: Formation of tube-like structures by vascular endothelial cells in vitro and angiogenesis in vivo. Biochemical and Biophysical Research Communications, 250(2), 444-448. https://doi.org/10.1006/bbrc.1998.9334
Fukushi, J., Ono, M., Morikawa, W., Iwamoto, Y., & Kuwano, M. (2000). The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13. Journal of Immunology, 165(5), 2818-2823. https://doi.org/10.4049/jimmunol.165.5.2818
Ghiso, J., & Frangione, B. (2001). Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia. Journal of Alzheimer's Disease, 3(1), 65-73. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12214074
Gopinathan, G., Milagre, C., Pearce, O. M., Reynolds, L. E., Hodivala-Dilke, K., Leinster, D. A., Zhong, H., Hollingsworth, R. E., Thompson, R., Whiteford, J. R., & Balkwill, F. (2015). Interleukin-6 stimulates defective angiogenesis. Cancer Research, 75(15), 3098-3107. https://doi.org/10.1158/0008-5472.CAN-15-1227
Gottardi, C. J., Arpin, M., Fanning, A. S., & Louvard, D. (1996). The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proceedings of the National Academy of Sciences, 93(20), 10779-10784. https://doi.org/10.1073/pnas.93.20.10779
Hartz, A. M., Bauer, B., Soldner, E. L., Wolf, A., Boy, S., Backhaus, R., Mihaljevic, I., Bogdahn, U., Klünemann, H. H., Schuierer, G., & Schlachetzki, F. (2012). Amyloid-beta contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke, 43(2), 514-523. https://doi.org/10.1161/STROKEAHA.111.627562
Hatanaka, K., Simons, M., & Murakami, M. (2011). Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. American Journal of Physiology. Heart and Circulatory Physiology, 300(1), H162-H172. https://doi.org/10.1152/ajpheart.00650.2010
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science, 274(5284), 99-102. https://doi.org/10.1126/science.274.5284.99
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Perez, J. M., Evans, A. C., & Alzheimer's Disease Neuroimaging Initiative. (2016). Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nature Communications, 7, 11934. https://doi.org/10.1038/ncomms11934
Jia, S. J., Lai, Y. Q., Zhao, M., Gong, T., & Zhang, B. K. (2013). Homocysteine-induced hypermethylation of DDAH2 promoter contributes to apoptosis of endothelial cells. Pharmazie, 68(4), 282-286. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23700795
Kamat, P. K., Vacek, J. C., Kalani, A., & Tyagi, N. (2015). Homocysteine induced cerebrovascular dysfunction: A link to Alzheimer's disease etiology. Open Neurol J, 9, 9-14. https://doi.org/10.2174/1874205X01509010009
Kamath, A. F., Chauhan, A. K., Kisucka, J., Dole, V. S., Loscalzo, J., Handy, D. E., & Wagner, D. D. (2006). Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood, 107(2), 591-593. https://doi.org/10.1182/blood-2005-06-2506
Kataoka, T. (2005). The caspase-8 modulator c-FLIP. Critical Reviews in Immunology, 25(1), 31-58. https://doi.org/10.1615/critrevimmunol.v25.i1.30
Kim, T. H., Zhao, Y., Barber, M. J., Kuharsky, D. K., & Yin, X. M. (2000). Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. The Journal of Biological Chemistry, 275(50), 39474-39481. https://doi.org/10.1074/jbc.M003370200
Korte, N., Nortley, R., & Attwell, D. (2020). Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease. Acta Neuropathologica, 140(6), 793-810. https://doi.org/10.1007/s00401-020-02215-w
Kowaltowski, A. J., Vercesi, A. E., & Fiskum, G. (2000). Bcl-2 prevents mitochondrial permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides. Cell Death and Differentiation, 7(10), 903-910. https://doi.org/10.1038/sj.cdd.4400722
Lai, W. K., & Kan, M. Y. (2015). Homocysteine-induced endothelial dysfunction. Annals of Nutrition & Metabolism, 67(1), 1-12. https://doi.org/10.1159/000437098
Lampugnani, M. G., Orsenigo, F., Gagliani, M. C., Tacchetti, C., & Dejana, E. (2006). Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. The Journal of Cell Biology, 174(4), 593-604. https://doi.org/10.1083/jcb.200602080
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T., Luyendijk, W., & Frangione, B. (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage Dutch Type. Science, 248(4959), 1124-1126. https://doi.org/10.1126/science.2111584
Li, A., Dubey, S., Varney, M. L., Dave, B. J., & Singh, R. K. (2003). IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. Journal of Immunology, 170(6), 3369-3376. https://doi.org/10.4049/jimmunol.170.6.3369
Li, J. G., Chu, J., Barrero, C., Merali, S., & Pratico, D. (2014). Homocysteine exacerbates beta-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles. Annals of Neurology, 75(6), 851-863. https://doi.org/10.1002/ana.24145
Li, J. G., & Pratico, D. (2015). High levels of homocysteine results in cerebral amyloid angiopathy in mice. Journal of Alzheimer's Disease, 43(1), 29-35. https://doi.org/10.3233/JAD-141101
Liu, W. Y., Wang, Z. B., Zhang, L. C., Wei, X., & Li, L. (2012). Tight junction in blood-brain barrier: An overview of structure, regulation, and regulator substances. CNS Neuroscience & Therapeutics, 18(8), 609-615. https://doi.org/10.1111/j.1755-5949.2012.00340.x
Love, S., & Miners, J. S. (2016). Cerebrovascular disease in ageing and Alzheimer's disease. Acta Neuropathologica, 131(5), 645-658. https://doi.org/10.1007/s00401-015-1522-0
Ma, Y., Yang, S., He, Q., Zhang, D., & Chang, J. (2021). The role of immune cells in post-stroke angiogenesis and neuronal remodeling: The known and the unknown. Frontiers in Immunology, 12, 784098. https://doi.org/10.3389/fimmu.2021.784098
Mahoney, E. R., Dumitrescu, L., Moore, A. M., Cambronero, F. E., De Jager, P. L., Koran, M. E. I., Petyuk, V. A., Robinson, R. A. S., Goyal, S., Schneider, J. A., Bennett, D. A., Jefferson, A. L., & Hohman, T. J. (2021). Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Molecular Psychiatry, 26(3), 888-896. https://doi.org/10.1038/s41380-019-0458-5
Martin, D., Galisteo, R., & Gutkind, J. S. (2009). CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. The Journal of Biological Chemistry, 284(10), 6038-6042. https://doi.org/10.1074/jbc.C800207200
Micheau, O., Solary, E., Hammann, A., & Dimanche-Boitrel, M. T. (1999). Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. The Journal of Biological Chemistry, 274(12), 7987-7992. https://doi.org/10.1074/jbc.274.12.7987
Nagai, Y., Tasaki, H., Takatsu, H., Nihei, S., Yamashita, K., Toyokawa, T., & Nakashima, Y. (2001). Homocysteine inhibits angiogenesis in vitro and in vivo. Biochemical and Biophysical Research Communications, 281(3), 726-731. https://doi.org/10.1006/bbrc.2001.4400
Narita, M., Shimizu, S., Ito, T., Chittenden, T., Lutz, R. J., Matsuda, H., & Tsujimoto, Y. (1998). Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proceedings of the National Academy of Sciences of the United States of America, 95(25), 14681-14686. https://doi.org/10.1073/pnas.95.25.14681
Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., Kyrargyri, V., Pfeiffer, T., Khennouf, L., Madry, C., Gong, H., Richard-Loendt, A., Huang, W., Saito, T., Saido, T. C., Brandner, S., Sethi, H., & Attwell, D. (2019). Amyloid beta oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes. Science, 365(6450). https://doi.org/10.1126/science.aav9518
Pan, L., Yu, G., Huang, J., Zheng, X., & Xu, Y. (2017). Homocysteine inhibits angiogenesis through cytoskeleton remodeling. Bioscience Reports, 37(5). https://doi.org/10.1042/BSR20170860
Parodi-Rullan, R., Ghiso, J., Cabrera, E., Rostagno, A., & Fossati, S. (2020). Alzheimer's amyloid beta heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis. Aging Cell, 19(11), e13258. https://doi.org/10.1111/acel.13258
Parodi-Rullan, R. M., Javadov, S., & Fossati, S. (2021). Dissecting the crosstalk between endothelial mitochondrial damage, vascular inflammation, and neurodegeneration in cerebral amyloid Angiopathy and Alzheimer's disease. Cell, 10(11). https://doi.org/10.3390/cells10112903
Poh, T. W., Huang, S., Hirpara, J. L., & Pervaiz, S. (2007). LY303511 amplifies TRAIL-induced apoptosis in tumor cells by enhancing DR5 oligomerization, DISC assembly, and mitochondrial permeabilization. Cell Death and Differentiation, 14(10), 1813-1825. https://doi.org/10.1038/sj.cdd.4402177
Provias, J., & Jeynes, B. (2014). Reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in Alzheimer's disease. Current Neurovascular Research, 11(3), 202-209. https://doi.org/10.2174/1567202611666140520122316
Rhodehouse, B. C., Mayo, J. N., Beard, R. S., Jr., Chen, C. H., & Bearden, S. E. (2013). Opening of the blood-brain barrier before cerebral pathology in mild hyperhomocysteinemia. PLoS ONE, 8(5), e63951. https://doi.org/10.1371/journal.pone.0063951
Robbins, E. M., Betensky, R. A., Domnitz, S. B., Purcell, S. M., Garcia-Alloza, M., Greenberg, C., Rebeck, G. W., Hyman, B. T., Greenberg, S. M., Frosch, M. P., & Bacskai, B. J. (2006). Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. The Journal of Neuroscience, 26(2), 365-371. https://doi.org/10.1523/JNEUROSCI.3854-05.2006
Rosell, A., Arai, K., Lok, J., He, T., Guo, S., Navarro, M., Montaner, J., Katusic, Z. S., & Lo, E. H. (2009). Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. Journal of Cerebral Blood Flow and Metabolism, 29(5), 933-943. https://doi.org/10.1038/jcbfm.2009.17
Rossin, A., Derouet, M., Abdel-Sater, F., & Hueber, A. O. (2009). Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling. The Biochemical Journal, 419(1), 185. https://doi.org/10.1042/BJ20081212
Sidibe, A., & Imhof, B. A. (2014). VE-cadherin phosphorylation decides: Vascular permeability or diapedesis. Nature Immunology, 15(3), 215-217. https://doi.org/10.1038/ni.2825
Solesio, M. E., Peixoto, P. M., Debure, L., Madamba, S. M., de Leon, M. J., Wisniewski, T., Pavlov, E. V., & Fossati, S. (2018). Carbonic anhydrase inhibition selectively prevents amyloid beta neurovascular mitochondrial toxicity. Aging Cell, 17(4), e12787. https://doi.org/10.1111/acel.12787
Solito, R., Corti, F., Fossati, S., Mezhericher, E., Donnini, S., Ghiso, J., Giachetti, A., Rostagno, A., & Ziche, M. (2009). Dutch and Arctic mutant peptides of beta amyloid (1-40) differentially affect the FGF-2 pathway in brain endothelium. Experimental Cell Research, 315(3), 385-395. https://doi.org/10.1016/j.yexcr.2008.11.002
Son, P., & Lewis, L. (2023). Hyperhomocysteinemia. In StatPearls.
Sudduth, T. L., Powell, D. K., Smith, C. D., Greenstein, A., & Wilcock, D. M. (2013). Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation. Journal of Cerebral Blood Flow and Metabolism, 33(5), 708-715. https://doi.org/10.1038/jcbfm.2013.1
Suhara, T., Fukuo, K., Yasuda, O., Tsubakimoto, M., Takemura, Y., Kawamoto, H., Yokoi, T., Mogi, M., Kaimoto, T., & Ogihara, T. (2004). Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension, 43(6), 1208-1213. https://doi.org/10.1161/01.HYP.0000127914.94292.76
Take, Y., Chikai, Y., Shimamori, K., Kuragano, M., Kurita, H., & Tokuraku, K. (2022). Amyloid beta aggregation induces human brain microvascular endothelial cell death with abnormal Actin organization. Biochemistry and Biophysics Reports, 29, 101189. https://doi.org/10.1016/j.bbrep.2021.101189
Thomas, T., Miners, S., & Love, S. (2015). Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia. Brain, 138(Pt 4), 1059-1069. https://doi.org/10.1093/brain/awv025
Tian, D., Qin, Q., Li, M., Li, X., Xu, Q., & Lv, Q. (2020). Homocysteine impairs endothelial cell barrier function and Angiogenic potential via the Progranulin/EphA2 pathway. Frontiers in Pharmacology, 11, 614760. https://doi.org/10.3389/fphar.2020.614760
Tinelli, C., Di Pino, A., Ficulle, E., Marcelli, S., & Feligioni, M. (2019). Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Frontiers in Nutrition, 6, 49. https://doi.org/10.3389/fnut.2019.00049
Tornavaca, O., Chia, M., Dufton, N., Almagro, L. O., Conway, D. E., Randi, A. M., Schwartz, M. A., Matter, K., & Balda, M. S. (2015). ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. The Journal of Cell Biology, 208(6), 821-838. https://doi.org/10.1083/jcb.201404140
Tyagi, N., Ovechkin, A. V., Lominadze, D., Moshal, K. S., & Tyagi, S. C. (2006). Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. Journal of Cellular Biochemistry, 98(5), 1150-1162. https://doi.org/10.1002/jcb.20837
Wang, H., Huang, L., Wu, L., Lan, J., Feng, X., Li, P., & Peng, Y. (2020). The MMP-2/TIMP-2 system in Alzheimer disease. CNS & Neurological Disorders Drug Targets, 19(6), 402-416. https://doi.org/10.2174/1871527319666200812223007
Wang, X., Bove, A. M., Simone, G., & Ma, B. (2020). Molecular bases of VEGFR-2-mediated physiological function and pathological role. Frontiers in Cell and Development Biology, 8, 599281. https://doi.org/10.3389/fcell.2020.599281
Wang, X. X., Zhang, B., Xia, R., & Jia, Q. Y. (2020). Inflammation, apoptosis and autophagy as critical players in vascular dementia. European Review for Medical and Pharmacological Sciences, 24(18), 9601-9614. https://doi.org/10.26355/eurrev_202009_23048
Weekman, E. M., & Wilcock, D. M. (2016). Matrix metalloproteinase in blood-brain barrier breakdown in dementia. Journal of Alzheimer's Disease, 49(4), 893-903. https://doi.org/10.3233/JAD-150759
Weekman, E. M., Winder, Z., Rogers, C. B., Abner, E. L., Sudduth, T. L., Patel, E., Dugan, A. J., Fister, S. X., Wasek, B., Nelson, P. T., Jicha, G. A., Bottiglieri, T., Fardo, D. W., & Wilcock, D. M. (2022). Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue. Alzheimers Dement (N Y), 8(1), e12368. https://doi.org/10.1002/trc2.12368
Wong, S. M., Jansen, J. F. A., Zhang, C. E., Hoff, E. I., Staals, J., van Oostenbrugge, R. J., & Backes, W. H. (2019). Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease. Neurology, 92(15), e1669-e1677. https://doi.org/10.1212/WNL.0000000000007263
Wylezinski, L. S., & Hawiger, J. (2016). Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of Adherens junctions. The Journal of Biological Chemistry, 291(44), 22913-22923. https://doi.org/10.1074/jbc.M116.729038
Xu, J., Chen, S., Ku, G., Ahmed, S. H., Xu, J., Chen, H., & Hsu, C. Y. (2001). Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. Journal of Cerebral Blood Flow and Metabolism, 21(6), 702-710. https://doi.org/10.1097/00004647-200106000-00008
Yamamoto, M., Ramirez, S. H., Sato, S., Kiyota, T., Cerny, R. L., Kaibuchi, K., Persidsky, Y., & Ikezu, T. (2008). Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. The American Journal of Pathology, 172(2), 521-533. https://doi.org/10.2353/ajpath.2008.070076
Yu, X., Ji, C., & Shao, A. (2020). Neurovascular unit dysfunction and neurodegenerative disorders. Frontiers in Neuroscience, 14, 334. https://doi.org/10.3389/fnins.2020.00334
Zegeye, M. M., Andersson, B., Sirsjo, A., & Ljungberg, L. U. (2020). IL-6 trans-signaling impairs sprouting angiogenesis by inhibiting migration, proliferation and tube formation of human endothelial cells. Cell, 9(6). https://doi.org/10.3390/cells9061414
Zhang, Q., Li, Q., Chen, Y., Huang, X., Yang, I. H., Cao, L., Wu, W. K., & Tan, H. M. (2012). Homocysteine-impaired angiogenesis is associated with VEGF/VEGFR inhibition. Frontiers in Bioscience (Elite Edition), 4(7), 2525-2535. https://doi.org/10.2741/e563
Zhuo, J. M., Portugal, G. S., Kruger, W. D., Wang, H., Gould, T. J., & Pratico, D. (2010). Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. Current Alzheimer Research, 7(2), 140-149. https://doi.org/10.2174/156720510790691326
Zhuo, J. M., & Pratico, D. (2010). Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Experimental Gerontology, 45(3), 195-201. https://doi.org/10.1016/j.exger.2009.12.005
Zinchuk, V., Zinchuk, O., & Okada, T. (2007). Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: Pushing pixels to explore biological phenomena. Acta Histochemica et Cytochemica, 40(4), 101-111. https://doi.org/10.1267/ahc.07002